Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Bausch + Lomb CorporationNYSE: BLCO
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue grows in line with its trailing trend
Q2 FY2026 revenue of $1.39B rose 8.7% year over year, in line with the +8.8% change in trailing-twelve-month revenue. Sequentially, it rose 11.7% from the prior quarter. Over 3 fiscal years it compounded at +10.6% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 11 analysts of $5.5B (+7.8%) for the fiscal year ending Dec 2026, a step up from the +6.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.39B+11.7% QoQ
- Last fiscal yearDec 2025
- $5.1B+6.5% YoY
- LTMJun 2026
- $5.32B+8.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +8.7% | +7.1% | -1.6 pp |
| 1 year | +6.5% | +7.8% | +1.4 pp |
| 3-year CAGR | +10.6% | +6.4% | -4.2 pp |
| 5-year CAGR | +6.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 5.1B USD
- Year-over-year change
- +6.5%
- 4-year CAGR
- +7.9%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.1B | +6.5% |
| FY2024 | 2024-12-31 | 4.79B | +15.6% |
| FY2023 | 2023-12-31 | 4.15B | +10.0% |
| FY2022 | 2022-12-31 | 3.77B | +0.1% |
| FY2021 | 2021-12-31 | 3.77B | — |
Revenue vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's LTM Jun 2026 revenue of $5.32B is the 2nd highest of the 10 companies compared; the peer median is $897.76M.
- Its year-over-year change of +8.8% is the 5th highest of 9, against a peer median of -2.7%.
- Over three fiscal years its annual growth of +10.6% compares with a peer median of +29.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $15.32B | +42.8% | +41.6% | |
| LTM Jun 2026 | $5.32B | +8.8% | +10.6% | |
| LTM Jun 2026 | $2.6B | -14.5% | -10.6% | |
| LTM Sep 2026 | $1.61B | +9.2% | +9.6% | |
| LTM Jun 2026 | $1.01B | -42.8% | +35.3% | |
| LTM Sep 2026 | $897.76M | +68.8% | +504.9% | |
| LTM Jun 2026 | $612.84M | +41.5% | +21.5% | |
| LTM Sep 2026 | $450.82M | -45.6% | +23.3% | |
| LTM Sep 2026 | $25.17M | -33.1% | +100.4% | |
| LTM Jun 2026 | $0 | — | — | |
| Peer median (excluding BLCO) | $897.76M | -2.7% | +29.3% | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.77B | 3.77B | 4.15B | 4.79B | 5.1B |
| Cost of Revenue | 1.47B | 1.52B | 1.64B | 1.87B | 2.31B |
| Gross Profit | 2.3B | 2.25B | 2.5B | 2.92B | 2.79B |
| Gross Margin | 61.0% | 59.7% | 60.4% | 60.9% | 54.8% |
| Research & Development | 271M | 307M | 324M | 343M | 371M |
| Selling, General & Admin | 1.39B | 1.48B | 1.74B | 2.08B | 2.23B |
| Operating Expenses | 1.97B | 2.04B | 2.37B | 2.76B | 2.61B |
| Depreciation & Amortization | 415M | 379M | 382M | 436M | 421M |
| EBITDA | 733M | 598M | 499M | 601M | 535M |
| EBITDA Margin | 19.5% | 15.9% | 12.0% | 12.5% | 10.5% |
| Operating Income | 329M | 207M | 130M | 162M | 188M |
| Operating Margin | 8.7% | 5.5% | 3.1% | 3.4% | 3.7% |
| Interest Income | 0 | 6M | 15M | 15M | 12M |
| Interest Expense | 0 | 146M | 283M | 399M | 431M |
| Other Income / Expenses | (11M) | (134M) | (296M) | (396M) | (505M) |
| Income Before Tax | 318M | 73M | (166M) | (234M) | (317M) |
| Pre-Tax Margin | 8.4% | 1.9% | -4.0% | -4.9% | -6.2% |
| Income Tax Expense | 125M | 58M | 82M | 71M | 35M |
| Net Income | 182M | 6M | (260M) | (317M) | (360M) |
| Net Margin | 4.8% | 0.2% | -6.3% | -6.6% | -7.1% |
| EPS (Basic) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| EPS (Diluted) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| Weighted Avg Shares | 350M | 350M | 350.5M | 351.8M | 353.8M |
| Weighted Avg Shares (Diluted) | 350M | 350M | 350.5M | 351.8M | 353.8M |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.